Read: 1696
Overview
Enhancing detection and prevention capabilities significantly improves patient outcomes and survival rates. For instance, patients in the UK diagnosed with lung cancer have an 83 one-year survival rate if detected at stage 1; however, this number drops dramatically to just 17 when diagnosed at stage 4. Early detection of potentially aggressive cancers can lead to better prognoses. Despite recent advancements that have increased the detection rates for common cancers such as breast, prostate, and ovarian cancer, many still face delays in diagnosis.
To address these challenges, researchers in Manchester are actively pursuing innovative strategies across various domns:
Cancer Biomarkers and Liquid Biopsies: Scientists develop novel methods to detect disease markers through liquid biopsies - non-invasive procedures that offer less risk compared to traditional biopsy techniques.
Research Themes: The Manchester Cancer Research Centre MCRC fosters interdisciplinary collaboration, focusing on several research themes including cancer biology, immunology, epidemiology, and clinical sciences.
Research in Manchester: This city showcases the power of team science through diverse research activities that leverage its rich history of scientific breakthroughs. Engaging patients and public involvement are core to ensuring research impact is maximized.
Manchester Cancer Research Nexus: The MCRC operates within a dynamic ecosystem that connects multiple centres of excellence, institutes, and teams working towards advancing cancer research.
Research Facilities: Access to state-of-the-art infrastructure, including biostatistical resources, high-performance computing facilities, and advanced laboratory equipment supports cutting-edge discoveries.
Disease-Specific Research: MCRC prioritizes studies across various disease sites to understand specific cancer mechanisms and tlor therapies more effectively.
Privacy and Data Protection: The Centre ensures the safeguarding of personal data through adherence to strict privacy laws, respecting confidentiality while conducting research.
The MCRC is committed to translating scientific knowledge into practical advancements that improve patient care outcomes through early detection and prevention strategies.
Contact Us
For inquiries or collaborations, please contact:
Manchester Cancer Research Centre
The University of Manchester
555 Wilmslow Road
Manchester, UK M20 4GJ
Phone: +44 0 161 306 0800
Eml: [email protected]
Information on Website: The University of Manchester is a proud member of the Manchester Academic Health Science Centre MAHSC.
Charitable Status: Registered with charitable number RC000797.
Website by Parker Design
that this information includes general contact detls for inquiries related to research, collaboration opportunities, and website design. For detled instructions or more specific questions about privacy policies or data protection laws, consult the appropriate legal resources or personnel at your institution.
This article is reproduced from: https://www.mcrc.manchester.ac.uk/research/research-themes/prevention-and-early-detection/
Please indicate when reprinting from: https://www.81le.com/Tumor_Cancer/Manchester_Cancer_Research.html
Early Cancer Detection Manchester Innovations Manchester Cancer Research Centre Insights Biostatistical Resources in Cancer Studies Advanced Laboratory Equipment for Cancer Research Privacy Protection in Cancer Data Management Disease Specific Cancer Research Manchester Focus